Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System
<p>Mesenchymal stromal cells (MSCs), formerly known as mesenchymal stem cells, are nonhematopoietic multipotent cells and are emerging worldwide as the most clinically used and promising source for allogeneic cell therapy. MSCs, initially obtained from bone marrow, can be derived from several...
محفوظ في:
| المؤلف الرئيسي: | Bella S. Guerrouahen (14153289) (author) |
|---|---|
| مؤلفون آخرون: | Heba Sidahmed (2632471) (author), Asma Al Sulaiti (14590691) (author), Moza Al Khulaifi (14166135) (author), Chiara Cugno (3441302) (author) |
| منشور في: |
2019
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors
حسب: Mashael Al-toub (3563303)
منشور في: (2022) -
Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling
حسب: Radhakrishnan Vishnubalaji (3563306)
منشور في: (2019) -
A Systems-level Characterization of the Differentiation of Human Embryonic Stem Cells into Mesenchymal Stem Cells*[S]
حسب: Anja M. Billing (1297773)
منشور في: (2019) -
Aberrant development of pancreatic beta cells derived from human iPSCs with FOXA2 deficiency
حسب: Ahmed K. Elsayed (13275302)
منشور في: (2022) -
Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
حسب: Khaoula Errafii (10914446)
منشور في: (2021)